LCC
CELG

Lincoln Capital Corp’s Celgene Corp CELG Stock Holding History

Lincoln Capital Corp’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,575
Closed -$1.21M – 60
2018
Q1 		$1.21M Sell
12,575
-16,800
-57% -$1.61M 1.13% 31
2017
Q4 		$3.07M Sell
29,375
-2,501
-8% -$282K 2.62% 17
2017
Q3 		$4.65M Buy
31,876
+1,296
+4% +$177K 4.15% 6
2017
Q2 		$3.97M Buy
30,580
+185
+0.6% +$22.7K 3.51% 11
2017
Q1 		$3.78M Buy
30,395
+1,544
+5% +$185K 3.38% 7
2016
Q4 		$3.34M Buy
+28,851
New +$3.21M 3.22% 12

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lincoln Capital Corp's CELG Position: Q2 2018 in Review

Lincoln Capital Corp sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 12,575 shares — an estimated $1.21M sold.

Lincoln Capital Corp first reported a position in CELG in Q4 2016 and held it in 6 quarters. The position peaked at $4.65M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Lincoln Capital Corp reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Lincoln Capital Corp sold 12,575 Celgene Corp shares in Q2 2018, an estimated $1.21M.
  • Lincoln Capital Corp first reported a position in Celgene Corp in Q4 2016 and held it in 6 quarters.
  • Lincoln Capital Corp's Celgene Corp position peaked at $4.65M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Lincoln Capital Corp's 13F filing for Q2 2018, filed 26 Jul 2018.